ArticleCell discovery2022

A novel cyclic γ-AApeptide-based long-acting pan-coronavirus fusion inhibitor with potential oral bioavailability by targeting two sites in spike protein.

Songyi Xue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.